Nondriver NSCLC: Adding Pembrolizumab to Platinum-Based Chemotherapy Targeted Oncology 4:12 6 years ago 141 Далее Скачать
KEYNOTE-024 update: pembrolizumab vs platinum-based chemotherapy in NSCLC VJOncology 3:04 4 years ago 500 Далее Скачать
Advanced-Stage Nondriver NSCLC: Frontline Options Targeted Oncology 3:35 6 years ago 21 Далее Скачать
Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC ecancer 3:44 5 years ago 208 Далее Скачать
Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment GRACE - Global Resource for Advancing Cancer Education 3:40 8 years ago 2 058 Далее Скачать
Pembrolizumab monotherapy for NSCLC: KEYNOTE-024 update VJOncology 1:02 6 years ago 258 Далее Скачать
KEYNOTE-407: pembrolizumab plus chemo improves OS and PFS in NSCLC VJOncology 2:53 3 years ago 420 Далее Скачать
Approaching Therapy for a Case of Nondriver NSCLC Targeted Oncology 3:10 6 years ago 36 Далее Скачать
Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents HMP Education 25:26 6 years ago 1 273 Далее Скачать
Pembrolizumab new option for firstline treatment of advanced lung cancer with high PDL-1 expression ecancer 3:10 7 years ago 277 Далее Скачать
Benefit of Pembrolizumab in NSCLC: The KEYNOTE Trials Targeted Oncology 4:47 6 years ago 70 Далее Скачать
Pembrolizumab plus chemo shows prolonged OS and PFS improvement vs chemo for squamous NSCLC ecancer 3:44 2 years ago 98 Далее Скачать
Considering Factors to Treat Non-Driver Patients With NSCLC With Bevacizumab Targeted Oncology 0:50 7 years ago 17 Далее Скачать
Ivy Elkins on Pembroluzumab in Combination with Platinum-Based Chemo in Recurrent EGFR/ALK+ NSCLC IASLC 2:03 3 years ago 138 Далее Скачать
Results of KEYNOTE-024 trial of pembrolizumab in NSCLC VJOncology 1:48 8 years ago 1 361 Далее Скачать
Atezolizumab improves on single-agent chemo for NSCLC not eligible for platinum-containing regimen ecancer 5:18 2 years ago 13 Далее Скачать
